Angiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization

Area of Science:

• Ophthalmology
• Molecular Biology
• Angiogenesis Research

Background:

• Angiopoietins are key regulators of angiogenesis.
• Gelatinases, like matrix metalloproteinase-9 (MMP-9), play a critical role in neovascularization.
• The angiopoietin-Tie-2 pathway's role in regulating gelatinase expression needs further elucidation.

Purpose of the Study:

• To investigate the role of angiopoietins in regulating gelatinase expression during angiogenesis.
• To determine if inhibiting the angiopoietin/Tek interaction can suppress retinal neovascularization in vivo.

Main Methods:

• Cultured retinal microvascular endothelial cells were stimulated with angiopoietins (Ang-1 and Ang-2).
• Newborn mice with induced retinal neovascularization were treated with a Tie-2 antagonist (muTek delta Fc).
• Real-time RT-PCR and histologic analysis were used to assess gelatinase expression and neovascularization.

Main Results:

• Angiopoietin-1 and Angiopoietin-2 stimulation increased matrix metalloproteinase-9 (MMP-9) expression in endothelial cells.
• Angiopoietin-2 expression was highest during maximal angiogenic response in mice.
• Treatment with the Tie-2 antagonist muTek delta Fc significantly inhibited retinal neovascularization (87%) and MMP-9 expression (80%) in a dose-dependent manner.

Conclusions:

• Angiopoietin-2 up-regulates gelatinases in microvascular endothelial cells, an early response in retinal neovascularization.
• Inhibiting angiopoietin binding to Tie-2 receptors suppressed retinal neovascularization and MMP-9 expression.
• Targeting the angiopoietin/Tie-2 interaction offers a potential therapeutic strategy for neovascular eye diseases.